| ATC Class | Antimicrobial | Number of prescriptions/1,000 inhabitants | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BC | AB | SK | MB | ON | QC | NB | NS | PEI | NL | |||
Roman numerals I to III indicate the ranking of antimicrobials based on importance in human medicine as outlined by the Veterinary Drugs Directorate. Certain antimicrobials were removed from this table due to low (< 0.01 prescriptions/1,000 inhabitants) to no sales reported among the provinces. These are: nalidixic acid, sulfonamides, combinations with other antimicrobials excluding trimethoprim, sulfadiazine, sulfamethoxazole, chloramphenicol, sulfamethizole, sulfapyridine, and sulfisoxazole. | ||||||||||||
| I | Amoxicillin and enzyme inhibitor | Combinations of penicillins, including ß-lactamase inhibitors (J01CR) | 19.97 | 23.69 | 18.21 | 19.05 | 16.49 | 26.01 | 20.82 | 24.75 | 46.14 | 51.87 |
| Cefixime | Third-generation cephalosporins (J01DD) | 4.02 | 4.05 | 1.75 | 2.92 | 4.94 | 4.46 | 2.80 | 4.92 | 14.01 | 7.67 | |
| Ofloxacin, ciprofloxacin, norfloxacin, levofloxacin, moxifloxacin | Fluoroquinolones (J01MA) | 87.10 | 93.47 | 68.38 | 90.15 | 93.48 | 111.37 | 92.44 | 83.23 | 110.04 | 162.80 | |
| Vancomycin | Glycopeptides (J01XA) | 0.44 | 0.22 | 0.07 | 0.13 | 0.22 | 1.25 | 0.15 | 0.25 | 0.16 | 0.21 | |
| Metronidazole | Imidazole (J01XD) | 18.68 | 20.83 | 24.01 | 20.48 | 19.17 | 15.13 | 18.10 | 20.80 | 17.49 | 25.95 | |
| Linezolid | Linezolid (J01XX) | 0.07 | 0.04 | 0.05 | 0.01 | 0.04 | 0.14 | 0.01 | 0.04 | 0.01 | 0.08 | |
| II | Ampicillin, amoxicillin, pivampicillin | Penicillins with extended spectrum (J01CA) | 142.36 | 165.03 | 250.45 | 187.22 | 186.19 | 88.76 | 160.59 | 165.37 | 176.87 | 302.22 |
| Penicillin G, penicillin V | ß-lactamase sensitive penicillins (J01CE) | 32.13 | 34.57 | 26.07 | 37.50 | 25.91 | 40.20 | 39.46 | 33.40 | 33.90 | 39.83 | |
| Cloxacillin | ß-lactamase resistant penicillins (J01CF) | 8.37 | 7.59 | 17.36 | 20.94 | 7.70 | 6.17 | 6.72 | 9.39 | 9.36 | 17.74 | |
| Cephalexin, cefadroxil | First-generation cephalosporins (J01DB) | 62.86 | 60.86 | 94.53 | 61.77 | 50.83 | 25.95 | 56.19 | 57.84 | 57.51 | 79.98 | |
| Cefaclor, cefprozil, cefuroxime axetil | Second-generation cephalosporins (J01DC) | 14.86 | 24.08 | 13.06 | 18.01 | 36.59 | 31.98 | 41.56 | 36.85 | 13.64 | 32.94 | |
| Sulfamethoxazole and trimethoprim, sulfadiazine and trimethoprim | Combinations of sulfonamides and trimethoprim, including derivatives (J01EE) | 35.46 | 35.64 | 59.76 | 45.63 | 32.20 | 21.51 | 44.45 | 52.93 | 57.61 | 59.10 | |
| Azithromycin, clarithromycin, erythromycin | Macrolides (J01FA) | 103.09 | 127.78 | 130.78 | 140.60 | 150.77 | 113.35 | 146.50 | 139.12 | 174.18 | 183.38 | |
| Clindamycin | Lincosamides (J01FF) | 22.80 | 27.15 | 30.41 | 16.61 | 22.78 | 19.70 | 21.85 | 21.57 | 15.95 | 18.50 | |
| Tobramycin | Aminoglycosides (J01GB) | 0.06 | 0.06 | 0.16 | 0.08 | 0.07 | 0.12 | 0.20 | < 0.01 | NPD | < 0.01 | |
| Fusidic acid | Steroid antibacterials (J01XC) | 0.02 | 0.01 | < 0.01 | 0.01 | 0.01 | 0.04 | 0.01 | 0.01 | 0.04 | NPD | |
| III | Doxycycline, minocycline, tetracycline | Tetracyclines (J01AA) | 38.80 | 43.65 | 60.53 | 35.28 | 29.98 | 35.72 | 30.53 | 44.47 | 47.77 | 39.27 |
| Trimethoprim | Trimethoprim and derivatives (J01EA) | 0.97 | 1.11 | 2.83 | 0.43 | 1.74 | 3.42 | 1.75 | 0.83 | 0.46 | 2.13 | |
| Nitrofurantoin | Nitrofuran derivatives (J01XE) | 28.39 | 22.70 | 40.92 | 17.52 | 34.59 | 15.19 | 26.69 | 36.56 | 25.16 | 19.76 | |
| Fosfomycin | Fosfomycin (J01XX) | 0.05 | 0.03 | 0.03 | < 0.01 | 0.01 | 0.01 | 0.02 | 0.08 | NPD | 0.01 | |
| NC | Methenamine | Methenamine (J01XX) | 0.23 | 0.14 | 0.10 | < 0.01 | 0.11 | 0.59 | 0.15 | 0.05 | NPD | 0.02 |
| Total (J01) | 620.73 | 692.70 | 839.47 | 714.34 | 713.82 | 561.08 | 711.02 | 732.46 | 800.31 | 1,043.47 | ||